A key trend in the medical device market is smaller and smarter, which requires advanced materials and is the focus of the ...

HeartFlow is set to be listed on the Nasdaq under the symbol ‘HTFL’. Seeking a valuation of $1.46bn, the California-based company aims to raise $300m by offering 16.7 million shares priced between $17 ...

MedTech Europe has reiterated the importance of tariff-free trade for medical technologies following the US decision to impose reciprocal tariffs of 15% on most goods from Europe.

Microbot Medical has secured a non-dilutive NIS2.15m (around $630,000) grant from the Israel Innovation Authority (IIA).

The FDA has granted a second 510(k) clearance to expand the use of Respiree’s RS001 cardio-respiratory wearable to home use.

Alcon has agreed to acquire struggling rival eyecare specialist STAAR Surgical in an equity deal valued at around $1.5bn.

BD has announced an investment exceeding $35m to expand the manufacturing of BD PosiFlush Prefilled Flush Syringes at its US facility.

The US FDA has conditionally approved TransMedics Group’s IDE to commence the next-generation OCS ENHANCE Heart study.

Regulatory and supply chain pressures place scaling medical device companies under strain. Expert partners can help ease these pain points.

To realise the potential of medical device data and maintain security protocols in a more connected medtech reality, network architecture must evolve.

Baxter’s share price declined by almost 23% on 31 July following the disclosure of disappointing Q2 2025 results that prompted the company to trim its 2025 profit outlook.

Becton, Dickinson and Company (BD) has announced its submission of an application to the FDA for an at-home human papillomavirus (HPV) test.